Results 201 to 210 of about 102,940,073 (295)

PULPO: pipeline of understanding large-scale patterns of oncogenomic signatures. [PDF]

open access: yesBioinformatics
Portasany-Rodríguez M   +11 more
europepmc   +1 more source

Elucidating PI3K/AKT/PTEN Pathway Alterations at Single‐Cell Level in CTCs From HR+/HER2− Metastatic Breast Cancer

open access: yesCancer Science, EarlyView.
Single CTC analysis revealed extensive inter‐ and intra‐patient heterogeneity of PI3K/AKT/PTEN pathway alterations in HR+/HER2− metastatic breast cancer, capturing both SNVs and CNAs, including PTEN loss‐of‐function events. Longitudinal CTC profiling also uncovered dynamic clonal evolution, highlighting its potential to complement tissue and ctDNA ...
Tania Rossi   +10 more
wiley   +1 more source

The UVA-induced single-base mutational signature of CX-5461 in human cells. [PDF]

open access: yesNucleic Acids Res
Zaikova E   +13 more
europepmc   +1 more source

Dynamic Changes of ctDNA‐Based MRD and Genomic Mutations Predict Prognosis in ESCC Treated With Definitive Radiotherapy

open access: yesCancer Science, EarlyView.
In patients with esophageal squamous cell carcinoma receiving definitive radiotherapy combined with systemic therapy, posttreatment TP53 mutation clearance and ctDNA‐MRD negativity predict favorable outcomes, whereas persistent ctDNA signals indicate elevated relapse risk, supporting nucleosome‐ and MRD‐informed surveillance and risk‐stratification ...
Shutang Liu   +9 more
wiley   +1 more source

COSMIC-Linked Ras Mutations at the Interface Between H-Ras and PI3Kγ<sub>RBD</sub> Frequently Generate Affinity Increases. [PDF]

open access: yesBiochemistry
Mead EH   +11 more
europepmc   +1 more source

Assessment of MRD and Longitudinal Monitoring of Post‐Surgery Biliary Tract Cancer With a Customized ctDNA Panel

open access: yesCancer Science, EarlyView.
A customized panel was established for BTC MRD detection. Preoperative ctDNA detection was associated with pathological stage and poorer RFS and OS. Longitudinal monitoring detected ctDNA before radiological recurrence in 72.7% of patients, with a median lead time of 77 days, supporting ctDNA as a complementary prognostic biomarker with CA19‐9 ...
Yoshihito Shinohara   +13 more
wiley   +1 more source

Mosaic KRAS Variant as a Cause of Developmental Eye Anomalies in an Individual With EncephaloCranioCutaneous Lipomatosis

open access: yesClinical Genetics, EarlyView.
We describe a girl presenting with structural eye anomalies and a constellation of features suggestive of the mosaic RASopathy EncephaloCranioCutaneous Lipomatosis (ECCL). Tissue‐specific investigations identified a mosaic KRAS variant at a mutational hotspot (p.[Ala146Pro]), prompting appropriate tumour surveillance.
Karthikah Jeganathan   +8 more
wiley   +1 more source

Mutational signature refitting on sparse pan-cancer data. [PDF]

open access: yesAlgorithms Mol Biol
Gilad G, Przytycka TM, Sharan R.
europepmc   +1 more source

Home - About - Disclaimer - Privacy